Arrowhead Stock Plunges, Alector Stock Surges On Drug News

While Alector teamed up with GlaxoSmithKline to develop two medications, Arrowhead suspended a study of a cystic fibrosis drug. The stock of Arrowhead has dropped, while the stock of Alector has risen./nRead More